Researchers in Manchester have discovered a connection between lifestyle conditions, and preexisting factors in elevating the risk of developing rheumatoid arthritis.
Researchers studied a sample of more than 25,000 people between the ages of 40-79 years and found that lifestyle factors had a bearing on the risk of developing the disease.
Researchers Unveil New Strategy To Fight Rheumatoid Arthritis
American scientists have zeroed in on a new strategy that holds promise for improved treatment of arthritis and other auto-immune disorders in people.
Advertisement
The study revealed that smoking, obesity and having diabetes considerably increased the risk of developing rheumatoid arthritis.
Professor Ian Bruce said: "The factors we studied give us vital clues to the early events in the process that ends in someone developing RA. They are also simple to ask about and can be used as part of a prevention programme. Our new wave of funding from the Medical Research Council and National Institute of Health Research has allowed us to move forward to the next stage in our attempt to prevent the development of this distressing condition."
Source: Medindia
Source: Medindia
New Drug Slows Rheumatoid Arthritis Joint Damage
In rheumatoid arthritis patients, tofacitinib - a novel oral medication was found to inhibit the progression of joint damage, show clinical trial results.
Advertisement
 Gene's Role in Rheumatoid Arthritis UncoveredResearchers from University of Michigan have found out why certain people are more likely to suffer from rheumatoid arthritis. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
